In federal courts across the nation more than 6,457 pending lawsuits are in process regarding Xarelto. All the xarelto lawsuit claims that xarelto causes dangerous side effects and often times fatal uncontrollable bleeding. Since there have been so many lawsuits filed against the manufacturers and having similar allegations, these cases have been consolidated in a multidistrict litigation (MDL), numbered MDL 2592. Xarelto have received two ‘black box’ warnings from the FDA. These warnings are the strictest warning a product can receive before being pulled completely from the market. The most serious potential side effect, complication and risk caused by Xarelto is severe internal bleeding that can result in death.
Xarelto (Rivaroxaban) is an FXa inhibitor indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and for extended risk reduction. The blood thinner xarelto is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. Xarelto was initially approved in 2011 and is one of the most recent blood thinners on the market. Xarelto medication is mostly prescribed to the patients who were gone through hip and knee replacement surgeries. It generally is prescribed as an alternative to warfarin (Coumadin), a blood thinner that began to be used in 1954. The patients took Xarelto to treat them from atrial fibrillation (irregular heart rhythm), hypertension, or other valvular heart conditions.
Recently another lawsuit has been filed against Xarelto manufacturers Bayer AG and Janssen (a division of Johnson & Johnson Corporation). The plaintiff has filed a lawsuit on behalf of her deceased father, who she claims in her court documents died as a result of excessive bleeding from an injury he experienced that caused bleeding in his brain. Doctors could not get his blood to clot due to his use of Xarelto. The suit was initially filed in Vermont under case number 2:14-cv-00159-CR in the state’s federal court, later transferred to join other similar cases in multidistrict litigation number 2592.
According to the court documents plaintiff claims that her father was prescribed Xarelto to treat his atrial fibrillation, a heart condition that can sometimes put patients at risk for blood clots or stroke. The plaintiff also states that her father had only been using Xarelto for a brief period. After the accident occurred he diagnosed with a parenchymal hemorrhage, which is a kind of fatal brain hemorrhage. He eventually died from the bleeding. The lawsuit alleges Bayer and Janssen Pharmaceuticals failed to adequately warn doctors as well as patients about the adverse effects cause by the life threatening drug Xarelto and the manufacturers were reckless in releasing the drug to market without a corresponding antidote, which can lead Xarelto to cause someone to bleed to death.
According to the plaintiffs manufacturers withheld information about the lack of an antidote along with the prescribing information and they claims that if the company had warned of the risks, then patients would have been prescribed the drug warfarin, a medication in which internal bleeding can be treated with dosages of Vitamin K. Studies have also reveals that the drug makers may have reduced the risk of patients dying on Xarelto from uncontrollable bleeding if they had provided stronger warnings and recommended blood monitoring during treatment.
If you or your love ones are facing any xarelto complication or serious bleeding event after taking Xarelto can take a legal action against the company. He/she can claim for reimbursement money against complication or any loss. We have an experience attorneys group who Investigating Lawsuits over Xarelto Bleeding Problems. We evaluate your case free of cost unless we win the case for you. Contact Drugsclaim.com for free and confidential case review.